Annual accounts
Total Exemption Full accounts
31/12/2026Filing deadline
- Next accounts made up to
- 31/03/2026
- Last accounts made up to
- 31/03/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Amended total exemption full accounts made up to 2025-03-31
Total exemption full accounts made up to 2025-03-31
Satisfaction of charge 1 in full
Confirmation statement made on 2025-12-09 with no updates
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/12/2026Filing deadline
Confirms the registry record is up to date
23/12/2026Filing deadline
The latest figures NATIONAL HEREDITARY BREAST CANCER HELPLINE filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £100.97K
Total Assets
2024: £191.16K
Cash in Bank
2024: £4.68K
Total Liabilities
2024: £90.18K
Employees
2024: 14
Of the 4 measures with an earlier filing to compare against, 4 fell. Total assets moved furthest, down 49.09% on 2024. See the full financial analysis for NATIONAL HEREDITARY BREAST CANCER HELPLINE.
The full financial record
Four ways through NATIONAL HEREDITARY BREAST CANCER HELPLINE's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 11 | -3 |
| 2024 | 14 | +1 |
| 2023 | 13 | -3 |
| 2022 | 16 | +3 |
| 2021 | 13 | – |
Reported employee count decreased from 13 in 2021 to 11 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 09/12/2011–09/12/2011 | 1469 | |
| Director | 06/03/2017–06/12/2017 | 4 | |
| Director | 07/12/2018–29/05/2019 | 0 | |
| Director | 21/01/2020–Present | 0 | |
| Director | 09/12/2011–07/10/2016 | 0 | |
| Secretary | 06/03/2017–28/06/2017 | 0 | |
| Director | 06/12/2017–21/10/2018 | 0 | |
| Director | 25/04/2017–07/07/2017 | 0 | |
| Director | 07/10/2016–13/02/2018 | 0 | |
| Director | 15/10/2019–08/12/2025 | 0 | |
| Director | 19/12/2011–18/09/2012 | 2 | |
| Director | 30/06/2018–21/10/2018 | 10 | |
| Director | 07/10/2016–06/12/2017 | 0 | |
| Director | 07/12/2017–21/10/2018 | 6 | |
| Director | 30/05/2019–11/07/2019 | 0 | |
| Director | 21/10/2018–Present | 0 | |
| Director | 08/12/2017–22/06/2018 | 2 | |
| Director | 21/10/2018–10/09/2024 | 4 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–10/12/2017 | 0 | |
| 07/10/2016–13/02/2018 | 0 | |
| 31/05/2019–Present | 0 | |
| 07/10/2016–06/12/2017 | 0 | |
| 06/04/2016–06/12/2017 | 0 | |
| 07/10/2016–06/12/2017 | 0 |
Every document on the Companies House record, newest first.
Amended total exemption full accounts made up to 2025-03-31
Total exemption full accounts made up to 2025-03-31
Satisfaction of charge 1 in full
Confirmation statement made on 2025-12-09 with no updates
–
Termination of appointment of John Victor Squires as a director on 2025-12-08
Total exemption full accounts made up to 2024-03-31
Confirmation statement made on 2024-12-09 with no updates
Termination of appointment of Adrian Paul Denny Fewings as a director on 2024-09-10
Total exemption full accounts made up to 2023-03-31
Director's details changed for Mr Adrian Paul Denny Fewings on 2023-12-08
Confirmation statement made on 2023-12-09 with no updates
Showing 12 of 17 filings
See when the next accounts and confirmation statement are due
2 UK companies are similar to NATIONAL HEREDITARY BREAST CANCER HELPLINE, sharing the same company status (Active), the same industry sector and activity group (Retail sale of other second-hand goods in stores (not incl. antiques)) and a comparable number of employees. The 2 closest matches are shown below to help you compare competitors and industry peers.
C/O EDVENTURE FROME COMMUNITY INTEREST COMPANY, The Welsh Mill, Park Hill Drive, Frome, Somerset BA11 2LE
The Great Oak Hall, Westonbirt, The National Arboretum, Tetbury, Gloucestershire GL8 8QS
A short description of the company, written from its Companies House record.
NATIONAL HEREDITARY BREAST CANCER HELPLINE is a private limited company by guarantee without share capital, use of "limited" exemption registered in the United Kingdom, based in Unit 71 Storforth Lane Trading Estate Storforth Lane, Hasland, Chesterfield, Derbyshire S41 0QZ. Companies House classifies its business as Retail sale of other second-hand goods in stores (not incl. antiques), one of 2 SIC classifications on its record. It has been on the register for 14 years 9 months.
The register currently records it as active. Its 2025 accounts report net assets of £38.91K and 11 employees.
Answered from this company's own registry record and filed figures.
Companies House records NATIONAL HEREDITARY BREAST CANCER HELPLINE under 2 registered business activities: Retail sale of other second-hand goods in stores (not incl. antiques) (47.79/9 - SIC 2007) and Other human health activities (86.90 - SIC 2007).
NATIONAL HEREDITARY BREAST CANCER HELPLINE is recorded as active on the Companies House register, and has been on it since 09/12/2011.
The most recent accounts Okredo holds cover 2025 and report net assets of £38.91K, total assets of £97.31K, cash in bank of £2.19K and total liabilities of £42.37K.
The most recent document on the record is dated 20/03/2026: Amended total exemption full accounts made up to 2025-03-31, 6 months ago.
On the current registry record, accounts are due by 31/12/2026 and the next confirmation statement is due by 23/12/2026.
Companies House lists 18 officers (2 currently in post) and 6 people with significant control (1 current).